China Shineway Pharmaceutical Group Limited (HKG: 2877)

China Shineway Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	7,358	5,492	5,733	5,205	4,007	5,708
Market Cap Growth	-12.91%	-4.22%	10.16%	29.89%	-29.80%	-8.18%
Enterprise Value	1,035	24	537	224	200	1,681
Last Close Price	9.74	6.82	6.72	5.73	4.05	5.25
PE Ratio	6.21	4.84	6.21	6.33	8.74	7.33
PS Ratio	1.63	1.10	1.28	1.32	1.27	1.89
PB Ratio	0.93	0.71	0.79	0.72	0.58	0.88
P/FCF Ratio	6.81	6.32	5.17	6.96	5.89	18.25
P/OCF Ratio	4.60	5.34	4.57	6.03	5.28	13.87
EV/Sales Ratio	0.23	0.00	0.12	0.06	0.06	0.56
EV/EBITDA Ratio	0.86	0.02	0.53	0.26	0.27	2.23
EV/EBIT Ratio	1.02	0.02	0.67	0.34	0.40	3.15
EV/FCF Ratio	0.96	0.03	0.48	0.30	0.29	5.37
Debt / Equity Ratio	0.05	0.04	0.00	0.00	0.07	0.07
Debt / EBITDA Ratio	0.31	0.26	0.01	0.02	0.62	0.59
Debt / FCF Ratio	0.35	0.38	0.01	0.02	0.68	1.45
Asset Turnover	0.45	0.51	0.51	0.45	0.37	0.39
Inventory Turnover	1.28	1.44	1.63	1.58	1.53	1.73
Quick Ratio	3.09	2.97	3.66	4.62	3.96	3.96
Current Ratio	3.48	3.35	4.07	5.19	4.62	4.42
Return on Equity (ROE)	15.81%	14.45%	11.77%	9.52%	5.10%	8.72%
Return on Assets (ROA)	6.29%	6.81%	5.78%	4.63%	3.68%	4.30%
Return on Capital (ROIC)	8.07%	8.83%	7.25%	5.52%	4.27%	4.99%
Earnings Yield	20.43%	19.45%	14.25%	13.13%	8.74%	9.86%
FCF Yield	18.60%	15.81%	19.33%	14.37%	16.97%	5.48%
Dividend Yield	5.96%	6.78%	5.38%	8.36%	9.39%	4.91%
Payout Ratio	36.93%	32.72%	33.44%	81.39%	58.83%	35.53%
Buyback Yield / Dilution	-	-0.03%	0.21%	3.10%	4.51%
Total Shareholder Return	5.96%	6.78%	5.35%	8.57%	12.48%	9.42%

Source: S&P Capital IQ. Standard template. Financial Sources.